SAN DIEGO–(BUSINESS WIRE)–MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., will be available for direct purchase from MedImpact’s preferred partner, Birdi, Inc., by any licensed specialty … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the appointment of Michael Myshrall as chief financial officer (CFO). Myshrall brings over two decades of financial leadership experience in SaaS, artificial intelligence (AI) and technology sectors, positioning him to help … [Read more…]

Financing supports execution of early-stage clinical trials for Anocca’s lead programme VIDAR-1, powered by the Company’s leading-edge R&D platform, to target pancreatic cancer VIDAR-1 is the first non-viral gene-edited TCR-T cell therapy in Europe with recruitment open SÖDERTÄLJE, Sweden–(BUSINESS WIRE)–Anocca AB (‘Anocca’ or the ‘Company’), a leading clinical-stage T-cell immunotherapy company, has successfully raised SEK … [Read more…]

GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth is proud to announce the naming of the Bruce Braden Progressive & Metabolic Care Unit in recognition of a generous gift from philanthropist and longtime MarinHealth supporter Bruce Braden. His ongoing commitment to advancing access to exceptional diabetes and metabolic care has made a lasting impact on the lives of patients and … [Read more…]

One-Hour Event to Air Friday, August 15 Across All iHeartRadio Country Stations and The iHeartRadio App NEW YORK–(BUSINESS WIRE)–iHeartMedia is joining forces with Stand Up To Cancer® (SU2C) for the organization’s ninth biennial one-hour, commercial-free special airing Friday, August 15, at 8 p.m. ET and PT / 7 p.m. CT. The live event will be … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in … [Read more…]

Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth’s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces an increase in resources allocated to the liquidity contract entrusted to Kepler Cheuvreux. On 15 December 2017 Sensorion entered into a Liquidity Contract with Kepler … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$HIND–Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, … [Read more…]

LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.4 million for the second quarter of 2025 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $6.0 million and an operating loss of $5.8 million. For … [Read more…]